Oncology Central

Implementation of PSA-based active surveillance in prostate cancer


Prostate cancer screening had led to the diagnosis of a large proportion of localized and low-risk disease. Many of these cancer cases are believed to be indolent and would not be clinically perceived in the absence of screening. In addition to that, the wide use of active treatment has exposed these patients to treatment-related quality-of-life impact.

To view restricted content, please:

Leave A Comment